We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Walmart, UnitedHealth, Starbucks, Lam Research and Sinopec
Read MoreHide Full Article
For Immediate Release
Chicago, IL – August 17, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Walmart Inc. (WMT - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) , Starbucks Corporation (SBUX - Free Report) , Lam Research Corporation (LRCX - Free Report) and China Petroleum & Chemical Corporation .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Walmart, UnitedHealth and Starbucks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart, UnitedHealth and Starbucks. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Walmart have modestly outperformed the Zacks Supermarkets industry over the past year (+13.2% vs. +12.2%), but the stock has otherwise struggled lately to reflect the market's skepticism about the company's post-Covid positioning. The Zacks analyst believes that Walmart has been gaining from its sturdy comps record, driven by constant omnichannel efforts. This is evident from the fact that it has maintained it comps run in the U.S. division for 27 quarters on the trot.
Stay-at-home trends have been boosting e-commerce sales, which increased across all units in first-quarter fiscal 2022. With curbs being lifted, the company’s U.S. store environment is in good shape, while e-commerce also remains on the growth trajectory. The second-quarter earnings view, however, suggests a decline due to divestitures related to the International unit.
UnitedHealth shares have gained +26.6% over the last six months against the Zacks Medical Insurance industry’s gain of +22.4%. The Zacks analyst believes that UnitedHealth's continued growth at Optum and UnitedHealthcare segments have been driving revenues.
The company has been benefiting from a number of buyouts that have supplemented its organic growth and increased the scale and size of its business. Its solid health services segment offers significant diversification benefits. Pandemic-induced volatility, however, has been weighing on the company’s international and commercial businesses.
Shares of Starbucks have gained +5.6% in the past three months against the Zacks Food & Restaurants industry’s gain of +6.5%, however, it reported third-quarter fiscal 2021 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
The Zacks analyst believes that the company has been benefiting from initiatives like opening stores in new and existing markets, remodeling existing stores, controlling costs as well as aggressive product innovation and brand building. Starbucks, however, cautioned of a slower recovery in China. It has narrowed both international and China same-store sales growth for fiscal 2021.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Walmart, UnitedHealth, Starbucks, Lam Research and Sinopec
For Immediate Release
Chicago, IL – August 17, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Walmart Inc. (WMT - Free Report) , UnitedHealth Group Incorporated (UNH - Free Report) , Starbucks Corporation (SBUX - Free Report) , Lam Research Corporation (LRCX - Free Report) and China Petroleum & Chemical Corporation .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Walmart, UnitedHealth and Starbucks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Walmart, UnitedHealth and Starbucks. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Walmart have modestly outperformed the Zacks Supermarkets industry over the past year (+13.2% vs. +12.2%), but the stock has otherwise struggled lately to reflect the market's skepticism about the company's post-Covid positioning. The Zacks analyst believes that Walmart has been gaining from its sturdy comps record, driven by constant omnichannel efforts. This is evident from the fact that it has maintained it comps run in the U.S. division for 27 quarters on the trot.
Stay-at-home trends have been boosting e-commerce sales, which increased across all units in first-quarter fiscal 2022. With curbs being lifted, the company’s U.S. store environment is in good shape, while e-commerce also remains on the growth trajectory. The second-quarter earnings view, however, suggests a decline due to divestitures related to the International unit.
(You can read the full research report on Walmart here >>>)
UnitedHealth shares have gained +26.6% over the last six months against the Zacks Medical Insurance industry’s gain of +22.4%. The Zacks analyst believes that UnitedHealth's continued growth at Optum and UnitedHealthcare segments have been driving revenues.
The company has been benefiting from a number of buyouts that have supplemented its organic growth and increased the scale and size of its business. Its solid health services segment offers significant diversification benefits. Pandemic-induced volatility, however, has been weighing on the company’s international and commercial businesses.
(You can read the full research report on UnitedHealth here >>>)
Shares of Starbucks have gained +5.6% in the past three months against the Zacks Food & Restaurants industry’s gain of +6.5%, however, it reported third-quarter fiscal 2021 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
The Zacks analyst believes that the company has been benefiting from initiatives like opening stores in new and existing markets, remodeling existing stores, controlling costs as well as aggressive product innovation and brand building. Starbucks, however, cautioned of a slower recovery in China. It has narrowed both international and China same-store sales growth for fiscal 2021.
(You can read the full research report on Starbucks here >>>)
Other noteworthy reports we are featuring today include Lam Research Corporation and Sinopec.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.